| Primary |
| Diabetes Mellitus |
43.3% |
| Type 2 Diabetes Mellitus |
25.8% |
| Hypertension |
9.2% |
| Blood Pressure |
2.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Myocardial Ischaemia |
1.6% |
| Analgesic Therapy |
1.3% |
| Benign Prostatic Hyperplasia |
1.3% |
| Cardiac Failure |
1.3% |
| Diabetes Mellitus Inadequate Control |
1.3% |
| Atrial Fibrillation |
1.0% |
| Dyslipidaemia |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Osteoporosis |
1.0% |
| Pain |
1.0% |
| Renal Failure |
1.0% |
| Renal Failure Chronic |
1.0% |
| Sleep Disorder |
1.0% |
| Antiplatelet Therapy |
0.6% |
|
| Pancreatitis |
11.8% |
| Urticaria |
11.8% |
| Death |
9.4% |
| Vomiting |
9.4% |
| Rash |
5.5% |
| Myocardial Infarction |
4.7% |
| Renal Failure |
4.7% |
| Angioedema |
3.9% |
| Glomerular Filtration Rate Decreased |
3.9% |
| Lip Swelling |
3.9% |
| Renal Impairment |
3.9% |
| Cardiac Failure |
3.1% |
| Liver Function Test Abnormal |
3.1% |
| Pancreatitis Acute |
3.1% |
| Rash Generalised |
3.1% |
| Renal Failure Acute |
3.1% |
| Rhabdomyolysis |
3.1% |
| Swollen Tongue |
3.1% |
| Blood Glucose Increased |
2.4% |
| Eye Operation |
2.4% |
|
| Secondary |
| Diabetes Mellitus |
31.3% |
| Chronic Obstructive Pulmonary Disease |
18.8% |
| Type 2 Diabetes Mellitus |
9.4% |
| Diabetic Neuropathy |
6.3% |
| Left Ventricular Dysfunction |
6.3% |
| Lipids Increased |
6.3% |
| Renal Failure |
6.3% |
| Ventricular Dysfunction |
6.3% |
| Vitamin B12 Deficiency |
6.3% |
| Renal Failure Chronic |
3.1% |
|
| Hepatitis Cholestatic |
23.1% |
| Pancreatic Carcinoma |
15.4% |
| Eyelid Oedema |
7.7% |
| Hypotension |
7.7% |
| Pancreatitis |
7.7% |
| Rash Erythematous |
7.7% |
| Renal Failure Acute |
7.7% |
| Tongue Oedema |
7.7% |
| Visual Impairment |
7.7% |
| Vomiting |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.2% |
| Diabetes Mellitus |
13.6% |
| Hypertension |
7.6% |
| Colorectal Cancer Metastatic |
6.8% |
| Benign Prostatic Hyperplasia |
3.4% |
| Blood Glucose Increased |
2.5% |
| Prophylaxis |
2.5% |
| Pruritus |
2.5% |
| Rash |
2.5% |
| Ascites |
1.7% |
| Atrial Fibrillation |
1.7% |
| Blood Cholesterol |
1.7% |
| Cardiac Disorder |
1.7% |
| Hyperglycaemia |
1.7% |
| Renal Failure |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Blood Pressure |
0.8% |
| Calcium Deficiency |
0.8% |
| Depression |
0.8% |
| Diabetic Retinal Oedema |
0.8% |
|
| Renal Tubular Necrosis |
12.5% |
| Urinary Tract Infection |
12.5% |
| Cardiac Disorder |
6.3% |
| Depression |
6.3% |
| Diabetic Ketoacidosis |
6.3% |
| Localised Infection |
6.3% |
| Lung Infection |
6.3% |
| Palpitations |
6.3% |
| Pancreatic Carcinoma |
6.3% |
| Pneumonia |
6.3% |
| Product Substitution Issue |
6.3% |
| Skin Burning Sensation |
6.3% |
| Visual Impairment |
6.3% |
| White Blood Cells Urine Positive |
6.3% |
|
